Contravisory Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.62M Sell
30,802
-377
-1% -$99.1K 1.52% 30
2026
Q1
$8.32M Sell
31,179
-4,624
-13% -$1.25M 1.7% 27
2025
Q4
$8.98M Sell
35,803
-1,128
-3% -$300K 1.78% 25
2025
Q3
$10.6M Sell
36,931
-1,431
-4% -$383K 2.05% 12
2025
Q2
$10.1M Buy
38,362
+37,147
+3,057% +$9.05M 1.98% 13
2025
Q1
$283K Buy
+1,215
New +$295K 0.06% 198
2019
Q1
Sell
-40,938
Closed -$4.44M 326
2018
Q4
$4.44M Sell
40,938
-710
-2% -$95.1K 1.92% 19
2018
Q3
$6.21M Sell
41,648
-1,534
-4% -$233K 2.23% 10
2018
Q2
$6.66M Sell
43,182
-552
-1% -$83.3K 2.43% 6
2018
Q1
$6.08M Sell
43,734
-1,681
-4% -$247K 2.24% 9
2017
Q4
$6.22M Sell
45,415
-4,424
-9% -$585K 2.26% 11
2017
Q3
$6.46M Sell
49,839
-2,934
-6% -$391K 2.31% 10
2017
Q2
$6.99M Sell
52,773
-2,285
-4% -$280K 2.52% 8
2017
Q1
$6.79M Sell
55,058
-6,341
-10% -$751K 2.39% 8
2016
Q4
$6.77M Sell
61,399
-2,187
-3% -$243K 2.3% 15
2016
Q3
$7.51M Sell
63,586
-3,148
-5% -$371K 2.42% 14
2016
Q2
$7.47M Sell
66,734
-5,043
-7% -$543K 2.29% 19
2016
Q1
$7.22M Sell
71,777
-3,651
-5% -$350K 2.11% 22
2015
Q4
$8.01M Sell
75,428
-12,579
-14% -$1.3M 2.13% 24
2015
Q3
$8.2M Buy
+88,007
New +$9.1M 1.93% 33

Other funds holding LH

Contravisory Investment Management's LH Position: Q2 2026 in Review

Contravisory Investment Management reduced its Labcorp (LH) stake by 1.2% in Q2 2026, selling an estimated $99.1K and leaving 30,802 shares worth $8.62M. The position accounts for 1.52% of the portfolio, ranked #30.

Contravisory Investment Management first reported a position in LH in Q3 2015 and has held it in 20 quarters since. The position peaked at $10.6M in Q3 2025. 215 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Contravisory Investment Management held 30,802 shares of Labcorp worth $8.62M as of Q2 2026.
  • Contravisory Investment Management sold 377 Labcorp shares in Q2 2026, an estimated $99.1K.
  • Labcorp made up 1.52% of Contravisory Investment Management's portfolio in Q2 2026, its #30 holding.
  • Contravisory Investment Management first reported a position in Labcorp in Q3 2015 and has held it in 20 quarters since.
  • Contravisory Investment Management's Labcorp position peaked at $10.6M in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.